Navigation Links
PAREXEL Reports Fourth Quarter and Fiscal Year 2008 Financial Results
Date:8/6/2008

>

Total revenue $331,927 $253,982

Investigator fees 48,180 32,689

Gross revenue $380,107 $286,671

DSO 63 49

Capital expenditures $21,955 $14,014

(a) Fiscal Year 2007 numbers have been adjusted to reflect Fiscal Year

2008 presentation. Certain direct costs have been moved to selling,

general and administrative to ensure consistency among all business

segments.

PAREXEL International Corporation

Segment Information

($ in thousands)

Twelve months ended

June 30,

2008 2007 (a)

Clinical Research Services (CRS)

Service revenue $745,641 $548,838

% of total service revenue 77.3% 74.0%

Gross profit $251,762 $190,283

Gross margin % of service revenue 33.8% 34.7%

PAREXEL Consulting & Medical Communications

Services (PCMS)

Service revenue $129,804 $120,636

% of total service revenue 13.5% 16.3%

Gross profit $43,874 $36,161

Gross margin % of service revenue 33.8% 30.0%

Perceptive Informatics, Inc. (PII)

Service revenue $88,838 $72,481

% of total service revenue 9.2% 9.8%

Gross pr
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. PAREXEL Promotes Dr. Mark A. Goldberg to Chief Operating Officer
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2008 Earnings Release and Conference Call
3. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
4. PAREXEL Expands Global Clinical Logistics Capabilities
5. Parexel Invites Public to Listen to Live Webcast of Its Investor Day June 25, 2008
6. PAREXEL Enhances Early Phase Clinical Development Offering for Central Nervous System Studies
7. PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting
8. PAREXEL Reaches Agreement To Acquire ClinPhone
9. PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. PAREXEL Product Development and Regulatory Experts to Attend the 2008 BIO International Convention
11. PAREXEL Appoints Leading Biostatistician Dr. Imogene Grimes to Vice President of Data Sciences Strategic Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... SAN DIEGO and TORONTO ... APTO ; TSX: APS), a clinical-stage company developing ... today announced that the U.S. Food and Drug Administration ... APTO-253 for the treatment of acute myeloid leukemia (AML). ... the company,s lead product candidate in a Phase Ib ...
(Date:6/2/2015)... MIAMI (PRWEB) June 02, 2015 Global ... Latin America distributor for Bioquark, Inc.’s biologic products for the ... is the latest in Global Stem Cells Group’s ambitious expansion ... region’s growing demand for access to regenerative medicine and stem ... on the development of biologics that have the ability to ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/6wjpd6/bioburden_testing ) has announced the ... , Test, Application & End User - Forecast to ... bioburden testing market is expected to reach $565.6 Million ... a CAGR of 9.8% from 2014 to 2019 ... market is segmented into consumables and instruments. The consumables ...
(Date:6/2/2015)... Jun. 02, 2015 Tauriga Sciences, Inc. (OTCQB:  ... sciences company with interests in the natural wellness ... platform technology, today announced that it has officially ... ("Typenex") in exchange for a one-time cash payment ... Company and Typenex entered into a Settlement Agreement ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 2Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells 3Bioburden Testing Market 2015 - Global Forecasts to 2019 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4
... Nov. 21 Gen-Probe,s (Nasdaq: GPRO ... new molecular tool to more,accurately detect high-risk human ... or precancerous lesions, according to nine,oral presentations and ... Gen-Probe researchers at the international conference of the,European ...
... of NC,s biotechnology sector is $45.8 billion, 180,007 jobs , ... Nov. 20 North Carolina has invested more than $1 ... years, and the annual economic impact exceeds $45 billion, according ... , , Norris Tolson, president ...
... Discovery Channel, will showcase the cutting edge technology and on-site laboratories ... ... (Vocus) November 20, 2008 -- Lake Erie Biofuels, LLC , ... biodiesel in the Northeastern United States and will soon be introduced ...
Cached Biology Technology:Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5Discovery Channel to Feature Lake Erie Biofuels, LLC 2Discovery Channel to Feature Lake Erie Biofuels, LLC 3
(Date:6/1/2015)... June 1, 2015 According to ... Sensing Market by Technology (Touch-based & Touchless), Application (Consumer ... & by Geography - Global Forecast to 2020", published ... is expected to reach $23.55 Billion by 2020, at ... Browse 83 market data T ables ...
(Date:6/1/2015)... 2015 According to a ... by Application (Government, Military & Defense, Healthcare, Banking ... Security), Technology (Face Recognition, Fingerprint Recognition, Iris Recognition, ... and Others), Function (Contact and Non-Contact) & Geography ... Europe , APAC, Row) - Global Forecast ...
(Date:5/29/2015)... 28, 2015 Research and Markets ( ... "Facial Recognition Market by Solution, by Software, ... to 2020" report to their offering. ... recognition technology become more efficient and cost effective. ... and investment from the commercial sector. The development ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... European Experts in the field of life in extreme ... Antarctic Survey offices in Cambridge (UK) to officially kick ... on life in Extreme Environments). , Life in Extreme ... Europe has considerable expertise but a relatively fragmented research ...
... of the oxygen we breathe today is being produced ... scientists heard today (Wednesday 2 April 2008) at the ... week at the Edinburgh International Conference Centre. About ... photosynthesising creatures called phytoplankton in the major oceans. These ...
... HARBOR, N.Y. (Tuesday, April 1, 2008) Identifying ... in the mouse used to be a monumental task. ... making it effective for even the smallest laboratories. ... ( www.cshprotocols.org/TOCs/toc4_08.dtl ) highlights a method for screening ...
Cached Biology News:Cold Spring Harbor Protocols features methods to screen genomes and analyze evolution 2
Artisan™ Wash Solution (x 50) Additional Information: EU regulatory status: CE US regulatory status: IVD ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 25x0.2ml tubes...
... RNA stain is used to stain and ... agarose gels and does not interfere with ... nm transilluminator, the stain emits a red-orange ... film or with a CCD camera-based gel ...
... mitochondrial transmembrane potential is one ... that occur following induction of ... Kit utilizes a lipophilic cation, ... mitochondrial activity marker. MitoLight partitions ...
Biology Products: